Nationwide Fund Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-176,550
Closed -$2.52M 2403
2017
Q3
$2.52M Sell
176,550
-836
-0.5% -$11.9K 0.01% 1338
2017
Q2
$2.79M Buy
177,386
+131
+0.1% +$1.89K 0.01% 1284
2017
Q1
$2.45M Sell
177,255
-33,389
-16% -$467K 0.01% 1312
2016
Q4
$3.73M Sell
210,644
-954
-0.5% -$16.8K 0.02% 1135
2016
Q3
$4.08M Hold
211,598
0.02% 1073
2016
Q2
$4.13M Buy
211,598
+437
+0.2% +$8.57K 0.02% 1037
2016
Q1
$4.35M Sell
211,161
-301
-0.1% -$5.93K 0.02% 1010
2015
Q4
$4.34M Sell
211,462
-15,845
-7% -$304K 0.02% 999
2015
Q3
$3.89M Buy
227,307
+147,522
+185% +$2.7M 0.02% 1041
2015
Q2
$1.49M Sell
79,785
-4,580
-5% -$84.9K 0.01% 1616
2015
Q1
$1.61M Sell
84,365
-1,866
-2% -$34.5K 0.01% 1619
2014
Q4
$1.42M Sell
86,231
-11,627
-12% -$199K 0.01% 1608
2014
Q3
$1.73M Sell
97,858
-24,844
-20% -$488K 0.01% 1519
2014
Q2
$2.53M Sell
122,702
-14,787
-11% -$304K 0.01% 1350
2014
Q1
$3M Sell
137,489
-608
-0.4% -$13.9K 0.01% 1129
2013
Q4
$3.66M Buy
138,097
+1,348
+1% +$33.1K 0.02% 1115
2013
Q3
$3.23M Buy
136,749
+29,670
+28% +$693K 0.01% 1161
2013
Q2
$2.3M Buy
+107,079
New +$2.31M 0.01% 1209

Other funds holding VIVO

Nationwide Fund Advisors's VIVO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Meridian Bioscience Inc (VIVO) in Q4 2017, closing a stake of 176,550 shares — an estimated $2.52M sold.

Nationwide Fund Advisors first reported a position in VIVO in Q2 2013 and held it in 18 quarters. The position peaked at $4.35M in Q1 2016. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Meridian Bioscience Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 176,550 Meridian Bioscience Inc shares in Q4 2017, an estimated $2.52M.
  • Nationwide Fund Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Meridian Bioscience Inc position peaked at $4.35M in Q1 2016.
  • 178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.